[afro-nets] Merck to register 3-in-1 Gilead AIDS pill in poor countries

["Claudio Schuftan" <claudio@hcmc.netnam.vn>]

Merck to register 3-in-1 Gilead AIDS pill in poor countries
-----------------------------------------------------------

From: "Vern Weitzel" <vern@coombs.anu.edu.au

Monday February 19, 1:06 pm ET

Drug giant Merck & Co. plans to begin selling the three-in-one AIDS pill developed with Gilead Sciences Inc. in poor countries with high rates of HIV infection.

 Whitehouse Station, N.J.-based Merck (NYSE: MRK <http://finance.yahoo.com/q?s=mrk&d=t - News <http://finance.yahoo.com/q/h?s=mrk) will set the price of the pill on a sliding scale based on how poor a country is and how many of its population are infected with HIV.
 <http://us.ard.yahoo.com/SIG=12f6jn14b/M=542254.9010430.10734420.8049260/D=fin/S=97014619:LREC/Y=YAHOO/EXP=1172052415/A=4299695/R=0/SIG=12i3jqfer/*http://www.fool.com/shop/newsletters/18/ecap.htm?cid=599&source=esayhobox3750071

The tablet combines three drugs in one pill -- Viread and Emtriva from Gilead, and Sustiva from Bristol-Myers Squibb Co. (NYSE: BMY <http://finance.yahoo.com/q?s=bmy&d=t - News <http://finance.yahoo.com/q/h?s=bmy)

 Foster City-based Gilead (NASDAQ: GILD <http://finance.yahoo.com/q?s=gild&d=t - News <http://finance.yahoo.com/q/h?s=gild) agreed to the low-cost sales in poor countries in August. Under that deal, Gilead will make the pills, while Merck will distribute them.